z-logo
Premium
Effect of postdilatation following balloon expandable transcatheter aortic valve implantation
Author(s) -
Kawaguchi Tomohiro,
Yamaji Kyohei,
Ishizu Kenichi,
Morinaga Takashi,
Hayashi Masaomi,
Isotani Akihiro,
Kakumoto Shinichi,
Arai Yoshio,
Sakaguchi Genichi,
Shirai Shinichi,
Ando Kenji
Publication year - 2020
Publication title -
catheterization and cardiovascular interventions
Language(s) - English
Resource type - Journals
SCImago Journal Rank - 0.988
H-Index - 116
eISSN - 1522-726X
pISSN - 1522-1946
DOI - 10.1002/ccd.28676
Subject(s) - medicine , fluoroscopy , nuclear medicine , balloon , cardiology , radiology
Background Postdilatation after transcatheter heart valve (THV) implantation was associated with larger aortic valve areas in large‐scale registries; however, the specific effects of postdilatation are poorly understood. Methods and Results Among a total of 224 consecutive patients who underwent transcatheter aortic valve replacement using SAPIEN 3, 121 patients (54.0%) underwent postdilatation (same contrast volume: N = 101, +1 ml: N = 17, +2 ml: N = 3). THV diameter was assessed (a) during, (b) after implantation, (c) during postdilatation, and (d) after postdilatation by quantitative fluoroscopy. In the overall patients ( N = 224), acute recoil was observed from during implantation (23.0 ± 2.0 mm) to after implantation (22.5 ± 2.0 mm, p  < .001) with an absolute recoil of 0.52 ± 0.25 mm. After postdilatation ( N = 121), THV diameter significantly increased from 22.5 ± 2.0 mm to 22.9 ± 2.1 mm ( p  < .001), with smaller absolute recoil (0.39 ± 0.21 mm, p  < .001). Compared with those who did not undergo postdilatation, patients who underwent postdilatation had larger postprocedural THV area assessed by multi‐slice computed tomography (471.4 ± 78.1 mm 2 vs. 447.5 ± 76.3 mm 2 , p = .02) and larger effective orifice area (EOA) assessed by echocardiography throughout 1 year (at 30 day, 1.66 ± 0.33 cm 2 vs. 1.45 ± 0.27 cm 2 , p  < .001; at 6 month, 1.66 ± 0.33 cm 2 vs. 1.44 ± 0.29 cm 2 , p  < .001; at 1 year, 1.69 ± 0.38 cm 2 vs. 1.47 ± 0.30 cm 2 , p  < .001). Conclusions Postdilatation after implantation of the SAPIEN 3 valve produced a larger THV diameter with less acute recoil, followed by larger EOA throughout 1 year. Further studies are needed to evaluate the impact of postdilatation on long‐term clinical outcomes.

This content is not available in your region!

Continue researching here.

Having issues? You can contact us here